Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-22-037517

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schmid John P. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-15 Grant or award : show line 1 in the form Stock Option (right to buy) +15,000 15,000 D
Loading xslF345X03/doc4.xml…